Nebula Research & Development LLC cut its stake in Varex Imaging Co. (NASDAQ:VREX - Free Report) by 81.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,458 shares of the company's stock after selling 51,693 shares during the quarter. Nebula Research & Development LLC's holdings in Varex Imaging were worth $167,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Barclays PLC lifted its position in shares of Varex Imaging by 15.3% during the third quarter. Barclays PLC now owns 97,883 shares of the company's stock worth $1,166,000 after purchasing an additional 12,966 shares in the last quarter. Empowered Funds LLC lifted its holdings in Varex Imaging by 5.1% in the 4th quarter. Empowered Funds LLC now owns 166,977 shares of the company's stock worth $2,436,000 after buying an additional 8,104 shares in the last quarter. Savant Capital LLC purchased a new position in Varex Imaging in the 4th quarter valued at about $237,000. Principal Financial Group Inc. boosted its position in Varex Imaging by 10.5% in the 4th quarter. Principal Financial Group Inc. now owns 41,144 shares of the company's stock valued at $600,000 after buying an additional 3,914 shares during the last quarter. Finally, Rice Hall James & Associates LLC increased its position in shares of Varex Imaging by 240.7% during the fourth quarter. Rice Hall James & Associates LLC now owns 328,692 shares of the company's stock worth $4,796,000 after acquiring an additional 232,229 shares during the last quarter.
Analysts Set New Price Targets
VREX has been the subject of a number of analyst reports. Oppenheimer reduced their price target on Varex Imaging from $30.00 to $23.00 and set an "outperform" rating for the company in a report on Friday, February 7th. StockNews.com upgraded Varex Imaging from a "hold" rating to a "buy" rating in a research note on Friday, February 7th. Finally, B. Riley restated a "buy" rating and issued a $22.00 price target (up previously from $21.00) on shares of Varex Imaging in a research note on Friday, February 7th.
Check Out Our Latest Analysis on VREX
Insiders Place Their Bets
In other news, SVP Kimberley E. Honeysett sold 4,007 shares of the firm's stock in a transaction dated Thursday, March 20th. The shares were sold at an average price of $12.81, for a total value of $51,329.67. Following the transaction, the senior vice president now directly owns 4,002 shares in the company, valued at approximately $51,265.62. This trade represents a 50.03 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Sunny Sanyal sold 8,749 shares of the business's stock in a transaction dated Wednesday, April 2nd. The shares were sold at an average price of $11.24, for a total transaction of $98,338.76. Following the sale, the chief executive officer now directly owns 190,193 shares of the company's stock, valued at approximately $2,137,769.32. This represents a 4.40 % decrease in their position. The disclosure for this sale can be found here. 4.30% of the stock is currently owned by corporate insiders.
Varex Imaging Stock Down 1.2 %
Shares of VREX stock traded down $0.10 during trading hours on Wednesday, hitting $8.16. 37,514 shares of the company were exchanged, compared to its average volume of 566,820. The stock has a market capitalization of $336.19 million, a price-to-earnings ratio of -6.97 and a beta of 0.62. Varex Imaging Co. has a one year low of $6.97 and a one year high of $16.93. The business's 50-day simple moving average is $10.16 and its two-hundred day simple moving average is $12.81. The company has a debt-to-equity ratio of 1.02, a quick ratio of 2.50 and a current ratio of 4.36.
Varex Imaging (NASDAQ:VREX - Get Free Report) last released its earnings results on Thursday, February 6th. The company reported $0.07 EPS for the quarter, topping analysts' consensus estimates of $0.04 by $0.03. Varex Imaging had a positive return on equity of 4.00% and a negative net margin of 5.79%. Sell-side analysts predict that Varex Imaging Co. will post 0.53 EPS for the current fiscal year.
Varex Imaging Profile
(
Free Report)
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.
Featured Stories
Before you consider Varex Imaging, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Varex Imaging wasn't on the list.
While Varex Imaging currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
